Open AccessBivalirudin Anticoagulant Therapy With or Without Platelet Glycoprotein IIb/IIIa Inhibitors During Transcatheter Coronary Interventional Procedures
Author(s) -
Jiabei Li,
Shiyong Yu,
Dehui Qian,
Yun He,
Jun Jin,
Jiabei Li,
Jiabei Li,
Jiabei Li,
Jiabei Li,
Jiabei Li,
Shiyong Yu,
Shiyong Yu,
Shiyong Yu,
Shiyong Yu,
Shiyong Yu,
Shiyong Yu,
Shiyong Yu,
Shiyong Yu,
Shiyong Yu,
Shiyong Yu,
Dehui Qian,
Dehui Qian,
Dehui Qian,
Dehui Qian,
Dehui Qian,
Dehui Qian,
Dehui Qian,
Dehui Qian,
Dehui Qian,
Dehui Qian,
Yun He,
Yun He,
Yun He,
Yun He,
Yun He,
Yun He,
Yun He,
Yun He,
Yun He,
Yun He,
Jun Jin,
Jun Jin,
Jun Jin,
Jun Jin,
Jun Jin,
Jun Jin,
Jun Jin,
Jun Jin,
Jun Jin,
Jun Jin
Publication year - 2015
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000001067
Subject(s) - bivalirudin , medicine , eptifibatide , tirofiban , conventional pci , direct thrombin inhibitor , percutaneous coronary intervention , myocardial infarction , cardiology , randomized controlled trial , anticoagulant , heparin , warfarin , dabigatran , atrial fibrillation
Supplemental Digital Content is available in the text